RetinalGenix Technologies (RTGN) Research & Development (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Research & Development came in at $117064.0 in Q1 2026, up 785.91% year-on-year from $13214.0 in Q1 2025, and up 235.02% quarter-over-quarter from $34942.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Research & Development (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Research & Development across 7 years of filings, most recently posting $117064.0 for Q1 2026.
- Research & Development for Q1 2026 came in at $117064.0, up 785.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $186890.0 (down 38.4% YoY), and the FY2025 annual result was $83040.0, down 77.75% from the prior year.
- Research & Development came in at $117064.0 for Q1 2026 at RetinalGenix Technologies, up from $34942.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $317819.0 in Q4 2022 to a low of $13214.0 in Q1 2025.
- The 5-year median for Research & Development is $102977.0 (2024), against an average of $112165.5.
- Across the five-year window, Research & Development sank 84.1% in 2025 and surged 785.91% in 2026, its largest moves.
- RetinalGenix Technologies' Research & Development stood at $317819.0 in 2022, then plunged by 83.04% to $53896.0 in 2023, then jumped by 93.47% to $104271.0 in 2024, then slumped by 66.49% to $34942.0 in 2025, then soared by 235.02% to $117064.0 in 2026.
- The last three Research & Development figures came in at $117064.0 (Q1 2026), $34942.0 (Q4 2025), and $20454.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | RetinalGenix Technologies | - | - | - | 117,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,064.00 |
| Dec 31, 2025 | 34,942.00 |
| Sep 30, 2025 | 20,454.00 |
| Jun 30, 2025 | 14,430.00 |
| Mar 31, 2025 | 13,214.00 |
| Dec 31, 2024 | 104,271.00 |
| Sep 30, 2024 | 102,977.00 |
| Jun 30, 2024 | 82,926.00 |
| Mar 31, 2024 | 83,097.00 |
| Dec 31, 2023 | 53,896.00 |
| Sep 30, 2023 | 89,778.00 |
| Jun 30, 2023 | 152,577.00 |
| Mar 31, 2023 | 227,932.00 |
| Dec 31, 2022 | 317,819.00 |
| Sep 30, 2022 | 198,504.00 |
| Jun 30, 2022 | 135,439.00 |
| Mar 31, 2022 | 157,493.00 |
| Dec 31, 2021 | 182,244.00 |
| Sep 30, 2021 | 200,899.00 |
| Jun 30, 2021 | 159,941.00 |